Accepted for/Published in: JMIR Formative Research
Date Submitted: Sep 15, 2024
Open Peer Review Period: Oct 2, 2024 - Nov 27, 2024
Date Accepted: Feb 20, 2025
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Oxidative stress markers and prediction of severity by a machine learning approach in hospitalized patients with COVID-19 and severe lung disease: a feasibility study
ABSTRACT
Background:
Oxidative Stress (OS) is an imbalance between the production of free radicals and the body's ability to neutralize them, leading to damages of cells, proteins and deoxyribonucleic.
Objective:
To identify the relevant biomarkers of OS which could be associated to severity of hospitalized patients and to identify a possible correlation between OS biomarkers and clinical status of hospitalized COVID-19 patients with severe lung disease at hospital admission.
Methods:
All adult patients hospitalized with COVID-19 at the Infirmerie Protestante (Lyon, France) from 9th February 2022 to 18th May 2022 were included, regardless of the care service. The final sample consisted in 28 patients. Ten biomarkers were collected per patient (Zinc (Zn), Copper (Cu), Cu/Zn, Selenium, Uric acid, CRplus, Oxidized LDL, Glutathione peroxidase, Glutathione reductase and Thiols), as well as demographic variables and comorbidities. A support vector machine (SVM) model was used to predict the severity grade per patient, based on the collected data as training set.
Results:
: Three biomarkers of OS were associated with severity; Zn, Cu/Zn and Thiols especially for grade 0 (asymptomatic) and grade 1 (mild to moderate severity). The SVM model predicted the level of severity from the biological analysis of the OS biomarkers with only 7.14% of discrepancy in the training dataset.
Conclusions:
In case of COVID-19 infection, moderate to severe symptomatic patients are associated with a lowered zinc level, a lowered plasma thiol level, an increased CRPus and an increased Cu/Zn ratio among a panel of ten biomarkers of OS.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.